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Abstract
Obesity is reaching epidemic proportions and imposes major negative health crises and an economic burden in both high and
low income countries. The multifaceted nature of obesity represents a major health challenge, with obesity affecting a variety
of different organs and increases the risk of many other noncommunicable diseases, such as type 2 diabetes, fatty liver
disease, dementia, cardiovascular diseases, and even cancer. The defining organ of obesity is the adipose tissue, highlighting
the need to more comprehensively understand the development and biology of this tissue to understand the pathogenesis of
obesity. Adipose tissue is a miscellaneous and highly plastic endocrine organ. It comes in many different sizes and shades
and is distributed throughout many different locations in the body. Though its development begins prenatally, quite
uniquely, it has the capacity for unlimited growth throughout adulthood. Adipose tissue is also a highly sexually dimorphic
tissue, patterning men and women in different ways, which means the risks associated with obesity are also sexually
dimorphic. Recent studies show that environmental factors during prenatal and early stages of postnatal development have
the capacity to programme the structure and function of adipose tissue, with implications for the development of obesity.
This review summarizes the evidence for a role for early environmental factors, such as maternal malnutrition, hypoxia, and
exposure to excess hormones and endocrine disruptors during gestation in the programming of adipose tissue and obesity in
the offspring. We will also discuss the complexity of studying adipose tissue biology and the importance of appreciating
nuances in adipose tissue, such as sexual dimorphism and divergent responses to metabolic and endocrine stimuli. Given the
rising levels of obesity worldwide, understanding how environmental conditions in early life affects adipose tissue
phenotype and the subsequent development of obesity is of absolute importance.
Introduction
Obesity is classed as a global epidemic by the World Health
Organisation, with 13% of adults estimated to be obese in
2017 [1]. Although once only observed in high income
countries, the rate of obesity is now increasing in prevalence
in many middle and low income countries. The increased
incidence of obesity represents a major health challenge as
it increases the risk of developing other noncommunicable
diseases, including type 2 diabetes [2], fatty liver disease,
[3], cardiovascular diseases [4], and cancer [5]. In the UK,
the cost to the national health service for obesity was £6.1
billion in 2015, and the wider economic impact was £27
billion [6]. Many factors contribute to the development of
obesity. These include socio-economic factors and food
marketing, which contribute to population risk, as well as
genetic and lifestyle factors, which impact individual risk.
However, environmental factors during early life develop-
ment have the capacity to programme the structure and
function of organs in the body, including the adipose tissue,
the defining organ of obesity. Understanding how envir-
onmental conditions in early life impact adipose tissue
and the subsequent development of obesity is of absolute
importance.
The developmental origins of health and disease
(DOHaD) encompasses a field of research that correlates
long-term health and disease outcomes with early life
conditions. This field was initiated by findings of an asso-
ciation between fetal malnutrition, and the development of
metabolic diseases, like insulin resistance and obesity in
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adulthood [7, 8]. Extensions of this work using human
population and experimental animal data have shown that
exposure to a diverse array of suboptimal maternal envir-
onments, including nutritionally unbalanced diets, low
oxygen availability, and high body mass index (BMI) dur-
ing gestation, modifies the risk of the offspring developing
obesity [9, 10]. The aim of this review is to present the
findings of these studies. Particularly, the impact of a poor
gestational environment on the development and function of
the adipose and programming of obesity. It will first provide
information on adipose tissue biology, including the dif-
ferences and similarities between humans and the experi-
mental animal species used in the DOHaD field, as well as
describe sexual dimorphisms that exist in the adipose tissue
within species. This background information is rarely con-
sidered and is of key importance when comparing findings
to understand the developmental origins of obesity.
Adipose tissues
Adipose tissue is distributed throughout the body. Although
initially thought of as inert storage sites for triacylglycerol,
adipose tissue is now recognized as a dynamic endocrine
organ vital to whole body homeostasis and metabolism. In
mammals, adipose tissue is categorized as white adipose
tissue (WAT) and brown adipose tissue (BAT). While both
types are specialized to store lipids, they essentially have
antagonistic functions. WAT acts as an energy reservoir,
whereas BAT acts as an energy combustion site. Their
functions are carried out by mature white and brown adi-
pocytes, respectively. In addition to adipocytes, adipose
contains other cell types, like leukocytes, pericytes, and
endothelial cells. Moreover, both adipose types are vascu-
larised and innervated [11], connecting the tissue to whole
body metabolic regulation.
BAT was initially thought to be unique to neonates,
hibernators, and small mammals, which is unsurprising as
its primary function is to produce heat and these animals are
predisposed to temperature loss [12]. However, work in the
last decades has found that BAT is present in all mammals,
including adult humans [13, 14].
Brown adipocytes are derived from a common progenitor
with myocytes (Fig. 1) and are more closely related to
myocytes than to white adipocytes. Mature brown adipo-
cytes store lipids in multiple small vacuoles and have an
abundance of mitochondria, which are vital to heat pro-
duction. Breakdown of fatty acids in brown adipocytes
leads to an escalation of proton ions in the intermembrane
space of mitochondria. UCP1, an uncoupling protein that is
a key characteristic of brown adipocytes, uncouples this
proton gradient from the ATP production by increasing the
permeability of the inner mitochondrial membrane, leading
to heat production [15]. In addition to brown adipocytes
[16], BAT has many precursor cells, known as adipoblasts
or preadipocytes, present in the tissue.
In contrast to brown adipocytes, white adipocytes have
one large lipid droplet and few mitochondria. As the lipid
droplet occupies the majority of the cell, white adipocytes
have relatively little cytoplasm. White adipocytes are typi-
cally larger than brown (~100 µm in diameter versus
30 µm). White adipocytes differentiate from a separate
lineage to brown adipocytes (Fig. 1 and [17]), although like
BAT, WAT is full of progenitor cells. The presence of
preadipocytes in WAT allows it to be highly plastic and
capable of producing more mature white adipocytes when
necessary [18]. For instance, when caloric intake is high,
Fig. 1 Molecular pathways controlling the differentiation of
mesenchymal cells into brown and white adipocytes. Diagram
depicts key stages in cell differentiation from mesenchymal stem cells
to brown and white adipocytes, showing key cell markers at each cell
stage. Brown and white adipocytes are derived from mesenchymal
stem cells [156] and a number of factors control their differentiation.
However, the GSK3β and β-catenin-WNT signaling pathways are
particularly important for white adipocyte and brown adipocyte/
myocyte lineage commitment, respectively [157]. A zinc finger tran-
scriptional regulator, PRDM16 controls a bidirectional cell fate switch
between skeletal myoblasts and brown adipocytes [158]. Differentia-
tion of white adipocytes occurs down a separate lineage and adipo-
genesis of preadipocytes into mature adipocytes in WAT is controlled
by transcriptional regulators, including peroxisome proliferator-
activated receptor-γ (PPARγ) and CCAAT/enhancer-binding proteins
(C/EBPs) [20–24]. C/EBPα and C/EBPβ are expressed early in the
adipogenesis process along with certain zinc finger proteins, such as
ZFP423, they are expressed shortly after commitment to the white
adipocyte lineage and subsequently upregulate PPARγ [159]. These
molecular factors then operate together to regulate the expression of
other adipocyte-specific genes, resulting in the formation of mature
adipocytes [159].
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WAT increases its capacity for storing lipids, via both
adipocyte hyperplasia and hypertrophy [19, 20]. WAT is
also able to undergo a process known as “beiging”. Under
certain conditions, such as cold exposure, some white pre-
adipocytes can develop brown adipocyte characteristics,
including multiple lipid droplets, increased mitochondrial
density, and UCP1 expression [21]. These cells are known
as brite or beige adipocytes and alter WAT physiology by
affecting how it functions, and its hormonal output [22, 23].
Adipose depots, development, and differences
between species
The quantity of BAT and WAT at birth and in adulthood
differs greatly between species (Fig. 2). Human infants are
born exceptionally fat [24], with fat making up ~15% of a
neonate’s body weight. The closest experimental species to
humans in terms of fatness at birth is the guinea pig, with
~11% fat at birth [25], (Fig. 2A). There is also a wide
variation in the fat content of milk between species, with
most small species containing more fat compared to larger
species, like humans (Fig. 2A and [24–38]).
Humans are born with WAT depots that develops during
the final stages of gestation, with 90% being deposited
during the last 10 weeks of gestation. Guinea pigs, rabbits,
and sheep also accumulate WAT during the final third of
gestation [39, 40]. During this time, there is an increased
production of hormones, like insulin-like growth factors
(IGFs) and leptin in the fetus that promote fetal adipose
tissue growth [41–43]. However, mice and rats are born
without WAT, which develops in the first 14 days post birth
from progenitor cells in non-adipocyte structures [44].
Therefore, in terms of adipose development, the lactational
period in rodents may be more equivalent to the third tri-
mester of human pregnancy. Regardless, WAT depots tend
to expand as age increases in the majority of species.
The function and location of WAT is similar across
most species. Most WAT depots can be regarded pri-
marily as nutrient reserves and small amounts of fat are
distributed throughout the body in association with dif-
ferent organs. Ectopic fat stores can vary in their secre-
tory output and function based on their associated organ.
In the majority of mammals, the bulk of WAT is con-
tained in the superficial fascia between and within mus-
cles, below the peritoneum and in the bone marrow. WAT
depots are often also subdivided into either subcutaneous
adipose tissue, which lies under the skin, or visceral
adipose tissue, which lies inside the abdominal cavity in
association with internal organs.
BAT, however, is much more restricted in its distribution
and in most species the largest quantity of BAT is con-
centrated around the neck and spine (Fig. 2B). In contrast to
WAT, most animals are born with BAT and therefore
develop it prenatally. There are also some differences in
BAT differentiation across the main species studied. In
rabbits, guinea pigs, lambs, and humans, BAT is fully
mature and functional at birth, whereas in mice and rats,
although BAT is present at birth, it only matures 1–2 days
after birth. Moreover, in mice, rats, and guinea pigs, BAT
depots, including the interscapular BAT remain throughout
life with little reduction in size. Contrastingly, larger spe-
cies, like rabbits, sheep, cows, and humans are born with






WAT Development Milk 
Composition
Human 15.0 3,000 Fully mature at 
birth
2nd and 3rd Trimester 





10.8 80 Fully mature at 
birth
3rd Trimester 3.9% Fat
Lamb 3.0 4,000 Fully mature at 
birth
3rd Trimester 5.9% Fat
Calf 2.8 31,000 Fully mature at 
birth
Born with WAT 4.2% Fat
Mouse 2.1 1-2 Matures 1-2 
days post birth
Post birth during 
lactation (first 14 days)
12.1% Fat
Rabbit 2.0 54 Fully mature at 
birth
First appears on day 24 
of gestation
12.2% Fat
 fo 06 yad neewteB004,13.1giP
gestation and day 9 
postnatally
7.5% Fat
Rat 1.1 6 Matures 1-2 
days post birth
Post birth during 




Fig. 2 Adipose tissue in different model species. A Table comparing
adipose development in different model species, showing average birth
weight, average percentage fat at birth, timing of BAT and WAT
development and average percentage fat in species milk composition.
B Diagram depicting main adipose storage sites in different model
species. VAT visceral adipose tissue, SAT subcutaneous adipose tissue.
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BAT stores, but most of these are gradually replaced by
WAT after birth [13, 45, 46].
Sex differences in adipose tissue biology and
obesity
Adipose tissue composition and location differs between
sexes, with humans possibly displaying the most extreme
example. The average human male body is comprised of
14% fat whereas the female body is comprised of 27% fat
[47]. The disparity in adiposity can be observed as early as
late gestation [48] and may indicate there are sex differ-
ences in mesenchymal cell fate decision towards the muscle
versus adipocyte lineage.
There are also differences in localization of fat between
sexes. Females typically have a gynoid fat distribution,
where fat is stored around the hips and thighs, while males
typically display an android form of fat distribution, where
fat is stored around the waist [49, 50]. Increased adiposity in
women produces a relatively benign form of obesity,
whereas in males it is associated with higher risk for
hypertension, insulin resistance, diabetes, dyslipidemia, and
heart disease [51]. The higher risk associated with the
android form of obesity is thought to be caused by leak of
fatty acids from adipose into the portal vein, leading to
accumulation of fat in ectopic organs and subsequent lipo-
toxicity. The differences in adipose location between sexes
are thought to be largely caused by estrogen, as post-
menopausal women develop a more android distribution.
Sexual dimorphism is far less documented in other spe-
cies. Like humans, female rodents harbor greater fat mass
compared to males [52, 53]. In addition, ovariectomized
female mice demonstrate a similar patterning of adipose
tissue to males [52]. Furthermore, unlike their male coun-
terparts, several strains of female mice are relatively resis-
tant to obesity on a high-fat diet [54, 55], but this protection
can be removed by ovariectomy [56, 57]. Thus, fat pat-
terning in adult females is influenced by reproductive hor-
mones. There are also differences in BAT composition
between sexes; in rodents and humans, females have a
higher proportion of BAT compared to males. Thus, adi-
pose tissue is a sexually dimorphic tissue, which is influ-
enced by sex hormones and modifies the risk of obesity.
Maternal nutritional restriction and offspring
adiposity
Maternal nutritional restriction was the first type of dietary
manipulation to be studied in the context of DOHaD. The
long-term consequences of the 1944 Dutch famine was the
subject of the original epidemiological studies that led to the
DOHaD hypothesis. This work found that exposure to
famine particularly in the first trimester of pregnancy was
associated with an increased risk of the offspring develop-
ing obesity in adulthood [58, 59].
Maternal nutrient and caloric restriction in a number of
animal models has also been found to programme the off-
spring for increased adiposity ([60, 61] and Table 1).
Moreover, there is evidence that this increase in adiposity is
related to an increase in brown and beige adipose tissue in
particular species, namely guinea pigs [62], as well as
adipocyte hypertrophy in other species, like cows and
baboons [61, 63]. Enhanced adiposity is also accompanied
by changes in PPAR and UCP1/2 abundance in the adipose
of offspring from undernourished mothers, however the
timing of the maternal nutrient restriction seems to deter-
mine the nature of the molecular changes and level of
adiposity [60, 63–65]. There are also programmed changes
in the expression of mitochondrial-related genes, like PGC-
1α and lipid handling genes, like FATP1 in the offspring
adipose [61, 63]. Maternal nutrient restriction is often
accompanied by decreased fetal growth or birth weight of
the offspring [60, 62, 63, 65]. Thus, the greater propensity
to become obese may reflect metabolic adaptations to
optimize growth when nutrient supply is limited in utero,
but may be mal-adaptive and lead to excess storage of
nutrients when nutrient supply is not limited postnatally.
Symonds et al. found the timing of a nutrient restriction in
sheep plays a role in determining the offspring outcome
[26]. They found that exposure to maternal nutrient restric-
tion up to day 110 of sheep gestation (term= 145 days)
promoted adipose tissue deposition in the fetal lamb at term,
whereas continuing the nutrient restriction after this time
decreased adipose tissue mass. Bisham et al. [66] found that
restoring maternal diets to the same as controls after day 80
of gestation further stimulated fat deposition in the fetus.
Increased adiposity despite exposure to maternal nutrient
restriction was accompanied by an increased abundance of
IGF receptors, suggesting enhanced adipose tissue sensitiv-
ity to the anabolic effects of IGFs [67]. However, further
information on the cellular, metabolic, and molecular
changes governing alterations in offspring adiposity with
maternal nutrient restriction, especially with regards to tim-
ing of insult, require investigation.
Maternal low protein diets and offspring adiposity
Studying the impact of gestational exposure to maternal low
protein foods, may help to understand the recent rise in the
rates of obesity and other metabolic diseases in many
countries [68]. Observational studies in humans have shown
that low protein consumption during pregnancy correlates
with fetal growth restriction [69]. In addition, studies in
areas, such as South India where many women are vege-
tarian, have shown a correlation between reduced milk
protein intake and low birth weight [70].
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In contrast to the human studies, there is a large volume
of animal studies that have investigated the effects of a
maternal low protein diet on offspring adipose tissue
(Table 2). These involve examining the effects of a low
protein diet for the entirety of pregnancy, at particular stages
in gestation and continuing the low protein diet during
lactation and across generations. Some studies also expose
the offspring to different nutrient manipulations postnatally.
Overall, the available data suggest that maternal low protein
diets have a complex effect on adipose tissue biology, with
studies finding divergent molecular changes [71, 72].
Across various species, maternal low protein diet appears
to have a two stage impact on offspring adiposity (Table 2).
Maternal low protein diets tend to reduce offspring birth
weight and adiposity in early life [71, 73], and may even be
protective against the development of obesity in juvenile
offspring fed a high fat or obesogenic diet postnatally [74].
However, offspring from low protein fed mothers accumu-
late greater amounts of fat as they mature [75, 76] and often
display insulin resistance and hyperglycemia in adulthood
[77, 78]. Furthermore, as they get older, offspring from
protein restricted mothers have a greater sensitivity to the
obesogenic effect and metabolic dysfunction induced by
chronic exposure to high-fat diet [79]. However, data from
pigs has shown that calorically restricting offspring exposed
to a maternal low protein diet during gestation prevents the
programming of increased adiposity postnatally, although
molecular changes are still evident in the adipose tissue [74].
Studies in rats have shown that the effect of a maternal
low protein diet on offspring adiposity is still observed even
when the offspring is cross-fostered [80]. Moreover, there
are greater increases in fat mass in first and second gen-
eration males from mothers that had been subjected to
protein restriction during just gestation rather than gestation
and lactation [77]. These data highlight the importance of
nutrient supply in utero in determining offspring adiposity,
with possible consequences for the offspring in subsequent
generations. Indeed in sheep, even maternal protein
restriction during very late gestation can predispose off-
spring for enhanced visceral adiposity in postnatal life [73].
Work in cows also suggest that the timing of maternal
protein intake imbalance is an important determinant of
offspring adiposity [81].
Across the species surveyed, changes in offspring adip-
osity are accompanied by alterations in adipocyte size or
number, insulin signaling and metabolic protein levels,
including PPARγ, as well as inflammatory markers and
leukocytes in the adipose tissue of the offspring born from
low protein diet-fed mothers [71, 72, 78, 82]. Importantly
there are changes in leptin, adiponectin, and other important
hormones like IGFs in the adipose of offspring [81, 83],
which may contribute to their enhanced adiposity post-
natally. Finally, although less explored, offspring of low
protein diet-fed mothers show increased BAT thermogenic
activity and UCP1 expression [79], which may provide
some explanation for their initial protection against high-fat-
diet-induced obesity as young adults.
There is some evidence to suggest that adipose tissue
biology and obesity in female and male offspring may be
differentially programmed by exposure to a maternal low
protein diet during development [73, 81, 84] however,
further work is required.
Maternal obesity/obesogenic diets and offspring
adiposity
With the incidence of obesity among women of child-
bearing age rising, assessing the effect of maternal obeso-
genic diets on offspring metabolic outcomes is particularly
relevant. In humans, maternal obesity is associated with an
increased risk of their child having increased adiposity
during infancy and obesity in adulthood [85]. Compelling
evidence showing a role for developmental programming
rather than genetic factors in the maternal transmission of
obesity comes from studies of women who have undergone
bariatric surgery to reduce weight; siblings born of women
post surgery displayed a reduced prevalence of obesity
compared to those born before surgery [86, 87].
Animal studies assessing the effect of maternal obesity/
obesogenic diets on offspring adiposity broadly seem to
support human association data and show consistent out-
comes across species (Table 3). Offspring from obese/high-
fat diet-fed mothers show increased adiposity [88–90] and
adipocyte hypertrophy postnatally [89, 91]. They also often
show increased inflammatory marker expression and a
higher infiltration of macrophages and other immune cells
in their adipose tissue [89, 91, 92], which may reflect
lipotoxicity and likely contributed to the glucose intolerance
seen in such offspring. Indeed, offspring from mothers fed
obesogenic diet often also demonstrate decreased insulin
signaling protein levels in their WAT [89, 93].
Work in mice suggests that the duration of maternal high
fat diet consumption has little effect on the magnitude of
changes in offspring adiposity, as long as the diet was
consumed within 9 weeks of mating [89]. Other work has
shown that offspring of mothers consuming an obesogenic
diet during gestation may be more prone to dietary-induced
changes postnatally. For instance, rat offspring exposed to
maternal obesity show greater morphological changes,
including enhanced adipocyte hyperplasia in response to a
postnatal high-fat diet [94]. Finally, some research suggests
that programmed changes in offspring adipose biology may
be permanent, as an exercise intervention in mothers fed a
high-fat diet did not prevent the increased adiposity or
trigger beneficial changes in insulin signaling component
expression in their fetuses [95]. However, whether there are














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Developmental programming of offspring adipose tissue biology and obesity risk 1177
beneficial impacts of maternal exercise in ameliorating the
impacts of maternal obesity/obesogenic diets on offspring
later in life warrants investigation.
No studies have explored whether maternal obesity/
obesogenic diets programme changes in offspring BAT.
Similarly, whether maternal obesity/obesogenic diets pro-
gramme offspring adipose biology and obesity in a sex-
dependent manner have been under investigated. Of the
studies that have, there are differences in adipose tissue
morphology and leukocyte influx, as well as metabolic
phenotype between exposed male and female offspring
[92, 96]. However, the mechanisms underlying sexually
dimorphic alterations in programmed outcomes remains
unexplored.
Hypoxia and offspring adiposity
Hypoxia can have many deleterious effects on a developing
fetus and can be caused by a variety of situations, such as
placental insufficiency, maternal anemia, smoking, and
increased altitude [97, 98]. In humans, cigarette smoking in
early pregnancy increased the likeliness of the infant being
overweight at 3 years of age [99]. Experimentally, hypoxia
can also be induced by placing animals in chambers where
the availability of oxygen is reduced. The impact of hypoxia
on the developing fetus depends on a variety of factors,
including the severity of the hypoxic episode, duration, and
stage of gestation, however these have not be studied in the
context of programmed changes in offspring adipose biol-
ogy and obesity risk. In the studies available (Table 4),
exposure to hypoxia during gestation was linked to
increased offspring adiposity in adulthood [100, 101]. This
was related to an elevated expression of pro-inflammatory
markers in the adipose tissue of hypoxia exposed rodent
offspring compared to their normoxic counterparts [100].
Exposure to hypoxia during intrauterine development was
also associated with molecular changes, including enhanced
UCP1, DIO, and PPARγ expression in the adipose of sheep
fetuses, suggesting the adipose may be programmed
towards the beige phenotype [102]. However, further work
is required to assess the impact of gestational hypoxia and
influence of offspring sex.
Endocrine disruptors and offspring adiposity
In recent years, there has been an increasing body of research
into the effects of endocrine disruptors on human health and
development. The focus of these studies is on synthetic
chemicals known as persistent organic pollutants due to their
resistance to environmental and biological degradation and
accumulation in the environment and biological tissues [103].
These include; bisphenol A (BPA), which is found in clear
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Developmental programming of offspring adipose tissue biology and obesity risk 1179
which are found in products, such as shampoos, moisturizers,
and liquid soaps. Both these chemicals can disrupt biological
processes by acting as endocrine disruptors. There is accu-
mulating evidence from human and animal studies that shows
associations between exposure to organic pollutants and other
widely diffused toxins to an increased risk of metabolic
diseases, including obesity [104]. These synthetic chemicals
are thought to promote obesity in children and adults by
increasing adipogenesis [105, 106]. There is evidence that
BPA can traverse the placenta and reach the fetus in humans
and other species [107, 108]. In humans, maternal urinary
BPA has been associated with increased hip to waist ratios in
the offspring, an affect that was more severe in females [109].
Animal studies of BPA and phalate exposure in utero
have consistently shown to increase offspring adiposity in
later life (Table 5 and [106, 110–112]). In part, these
changes are associated with enhanced adipocyte size, infil-
tration of inflammatory leukocytes, and elevated expression
of lipogenic markers, like PPAR-γ and SREBP [113].
Developmental exposure to BPA has also been linked to
enhanced levels of oxidative stress in the adipose of
exposed offspring however, such an effect was not pre-
vented by exposure to a perinatal Mediterranean diet that is
known to offer protection against oxidative stress [114].
There may also be a greater number of adipocytes in the
BAT of adult mouse offspring exposed to phalate during
gestational and lactational development [111]. Likely due to
their endocrine disrupting effects, BPA and phalates have
been shown to exert sex-dependent impacts on offspring
adiposity [106, 110]. However, due to the low number of
studies that have specifically looked at sex-specific effects,
firm conclusive results are yet to be made. Given the
available data and their persistence in tissues, organic pol-
lutants, like BPA and phalates possibly play a key role in
the rapid epidemiological growth of obesity. However,
more studies are required to examine this.
Glucocorticoids and offspring adiposity
Glucocorticoids are a class of steroid hormones that are part
of the hypothalamic pituitary adrenal axis and play an
important role in fetal development, including the maturation
of fetal organs prior to birth [115, 116]. However, excess
exposure to glucocorticoids during gestation can slow growth
and development of the fetus with negative effects on off-
spring health and developmental programming. Maternal
stress, anxiety and depression during pregnancy have been
shown to increase fetal exposure to glucocorticoids [117].
The use of synthetic glucocorticoids to advance lung
maturation in pregnancies with threatened preterm birth also
increases fetal exposure to glucocorticoids. In humans,
maternal second trimester levels of corticotropin-releasing






































































































































































































































































































































































































































































































































































1180 A. Rodgers, A. N. Sferruzzi-Perri
glucocorticoids, are positively correlated with central adip-
osity in infants at 3 years of age [118]. In animal studies,
excess glucocorticoid exposure in utero was consistently
shown to programme the offspring for increased adiposity
(Table 6 and [119–123]). This was coupled with alterations
in adipocyte morphology, expression of lipogenic genes,
insulin signaling proteins and inflammatory cytokine
expression in the offspring WAT [124]. There were also
cellular and molecular changes in the BAT of offspring over-
exposed to glucocorticoids prenatally, namely decreased
UCP1 expression, increased lipid droplet size, upregulated
prolactin receptor and decreased mitochondria content, which
would be expected to compromise tissue function [64, 125].
However, sex effects have not been explored and further
work is required to identify the importance of length, timing
and level of glucocorticoid over-exposure during gestation to
the developmental programming of offspring adipose biology
and obesity.
Androgens and offspring adiposity
Androgens are steroid hormones that typically regulate the
development and maintenance of male characteristics.
Possibly the most well-known and typically investigated
androgen in developmental studies is testosterone. As a
lipid-soluble hormone, testosterone is thought to be able to
cross the placenta and this notion is supported by data
showing that fetal plasma testosterone concentration is
positively correlated with maternal testosterone [126]. For
obvious reasons, in utero androgen exposure is particularly
harmful to female offspring. There have been many studies
showing that excess testosterone in utero contributes to the
development of polycystic ovary syndrome (PCOS), which
is estimated to affect 10–20% of women in the UK [127].
Therefore, androgen exposure in utero is thought to be both
a cause and a consequence of PCOS, impacting the trans-
mission of the disease [128]. PCOS increases the risk of
type 2 diabetes and obesity in women, thus in utero
androgen exposure may both directly and indirectly have an
impact on adiposity in later life [129, 130]. However, PCOS
is not the only cause of excess androgen exposure in utero;
female dizygotic twins may also be exposed due to excess
androgens from their male twin during gestation. Moreover,
maternal testosterone concentration has been shown to
negatively correlate with birth weight and BMI in female
offspring [131].
As shown in Table 7, work in experimental animals has
shown that excess androgen exposure in utero or in early
neonatal life programmes the female offspring to have
changes in adipose tissue biology [132–135]. There is a
change in the size of WAT adipocytes [132, 136] and an
increase in chemokine and pro-inflammatory cytokine
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depending on the timing of the androgen exposure and
WAT depot in female offspring [132, 137]. Androgen
exposed female offspring also seem to have an additional
increase in pro-inflammatory cytokines when fed an obe-
sogenic diet postnatally [137]. Exposure of female offspring
to testosterone neonatally leads to increased BAT which is
dysfunctional [136], although whether prenatal exposure
also affects BAT phenotype postnatally has yet to be
explored. There is also a greater sensitivity of androgen
exposed female offspring to increase their body weight with
an obesogenic diet postnatally [137]. However, further
work is required to identify the importance of timing,
duration, and level of androgen over-exposure during
gestation, versus in the neonatal period to the programming
of offspring adiposity, in relation to the pathogenesis of
metabolic disorders like obesity and PCOS.
Programming mechanisms of adipose tissue
The programming mechanisms behind changes in adipose
remain elusive. The studies which do explore this broadly
involve evaluating epigenetic changes in the adipose tissue
and studying the adipogenic potential of mesenchymal stem
cells from exposed offspring. However, as WAT develops
postnatally in some species like rats and mice, changes
induced by maternal manipulations may also be the result of
alterations in other systems, particularly the hypothalamic
pituitary adrenal hormonal axis in the offspring during
gestation [138]. Indeed, as described above, there are links
between glucocorticoid over-exposure in utero and the
programing of obesity in the offspring.
Epigenetic mechanisms
Suboptimal maternal environments, particularly those which
occur during critical developmental windows may perma-
nently alter gene expression in offspring tissues via epige-
netic mechanisms. Such mechanisms include changes in
DNA methylation, histone modifications, and the expression
of noncoding RNAs. Certainly, a number of studies explor-
ing fetal programming of adipose tissue have suggested that
each of these epigenetic processes may contribute.
In the WAT of males from obese rats, there are alterations
in DNA methylation of CpG sites proximal to C/EBP-β and
Zfp423 genes, which encode key transcriptional factors
initiating adipogenic commitment and is consistent with the
increased expression of key adipogenic regulators, PPAR-γ,
C/EBP-α, and C/EBP-β [139]. In another study, exposure to
maternal obesity was also associated with lower Zfp423
promoter methylation levels and increased Zfp423 gene
expression in offspring adipose tissue in alliance with
enhanced adiposity [140]. In addition, a maternal low protein
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the methylation of CpG sites proximal to the leptin gene in
the adult offspring [141] and likely contributed to the
abnormalities in adipose tissue biology seen in other work on
the model. Some studies have also shown that changes in
offspring adiposity with gestational hypoxia are coupled with
changes in DNA methylation patterns in the adipose tissue
[101, 142]. There was also increased DNA methylation of the
Ppargc1a promoter in neonatal BAT and brown adipocyte
progenitor cells, which was linked with attenuated BAT
development in response to glucocorticoid over-exposure
during gestation [125]. Finally, the methylation of multiple
genes was aberrant in the visceral WAT of infant and adult
offspring exposed to excess androgens, which likely con-
tributed to the development of obesity and PCOS in the
experimental model [133].
Maternal obesity and high-fat diets have also been
associated with alterations in histone modifications in the
adipose tissue of adult offspring. Of note, maternal obesity
was associated with increased H3K4me1/H3K27ac histone
modifications in enhancer sites upstream of the leptin gene,
which correlated with enhanced leptin expression in the
WAT of male offspring [143]. Moreover, a maternal high-
fat diet during pregnancy lead to alterations in histone
modifications at the promoter regions of the adiponectin and
leptin gene in the WAT of offspring [144].
Noncoding RNAs have also been shown to play a role in
the fetal programming of adipose tissue. For example,
maternal obesity was associated with upregulated expres-
sion of miR-126, which negatively regulates insulin
receptor susbtrate-1 (IRS1) and this was correlated to
reduced IRS1 abundance and insulin sensitivity of the WAT
in exposed offspring [93]. Furthermore, maternal low pro-
tein diets during gestation were associated with an increase
in miRNA-483-3p levels, which is known to reduce adipose
adipogenesis [145].
Mesenchymal studies
To inform on the programming of obesity, mesenchymal
stem cells have been harvested from the umbilical cord of
offspring exposed to different in utero/maternal environ-
ments. Previous work has shown there is a positive corre-
lation between the preference of mesenchymal stem cell fate
decisions towards the adipocyte lineage and infant adiposity
[88, 146]. In addition, mesenchymal stem cells from infants
of obese mothers showed a decrease in the abundance of
β-catenin, which would favor adipocyte rather than myocyte
differentiation [88]. Consistent with this, the differentiation
of mesenchymal stem cells to adipocytes in vitro was
increased and adiposity greater in 5-month-old infants from
obese mothers [88]. Higher adiposity in infants of obese
mothers was also linked to increased lipid species content
and lipid transport gene expression in differentiated
adipocytes and elevated oxidative stress, lower amino acid
concentrations and expression of growth-promoting genes
in their differentiated neonatal myocytes [146].
Summary and conclusions
Alterations to the in utero environment as a result of sub-
optimal maternal conditions are related to programmed
changes in the development, structure, and function of
adipose tissue in the offspring. A variety of nutritional
manipulations and differing metabolic environments such as
low protein, caloric/nutrient restriction, obesity/obesogenic
diets have all been shown to impact offspring adipose
structure and function. Non-nutritional changes, such as
hypoxia and exposure to hormones and pollutants/synthetic
chemicals have also been shown to affect adipose tissue in
the offspring. The outcomes of these manipulations differ
and are dependent on the manipulation itself, that is, its
timing, duration, and severity. Across a variety of mam-
malian species, the impacts of certain manipulations, such
as low protein diet remains relatively consistent increasing
the reliability of this data. However, broadly speaking,
while the majority of investigations available studied pro-
grammed changes in whole body metabolism, the adipose
tissue was examined in a very limited capacity. The
majority of studies also analyse only one fat depot and as
discussed, these can vary greatly and are reflective of the
organ they are associated with. In addition, certain adipose
pads, particularly the subcutaneous adipose vary with off-
spring sex. The focus of investigations also tend to be on
WAT so the effect of maternal manipulations on the pro-
gramming of BAT development and function remains
relatively unknown.
The impact of sex on the fetal programming of adipose
tissue has been relatively under-studied. The majority of the
studies only investigated male offspring and of the studies
that do include female offspring, very few compare sexes.
The studies which do compare sexes frequently find dis-
parities in offspring outcomes. Given the multiple differ-
ences in adipose tissue between males and females
previously discussed, this is unsurprising. However, the
mechanisms underlying these disparities in outcome from
the same in utero environment remain uninvestigated. There
have been speculations that some sex differences may be
partly due to sex-specific epigenetic modifications operating
at the level of the placenta during development. The pla-
centa is the functional interface between mother and fetus
and the main determinant of maternal nutrient, oxygen, and
hormonal supply to the fetus during gestation [9, 147]. Of
note, Gallou-Kabani et al. showed that the global methy-
lation pattern of the placenta was different between male
and females, even though they were exposed to the same in
utero environment [148]. However, whether a placenta-
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specific manipulation is sufficient to programme alterations
in offspring adipose biology and obesity and do so, in a
manner influenced by fetal sex, are yet to be studied.
Indeed, previous work has shown that several of the
maternal environmental manipulations surveyed here affect
placental formation and function in association with chan-
ges in fetal growth and offspring phenotype [9, 147, 149–152].
The placenta likely plays a major role in mediating the
programmed alterations in offspring adipose development
and function, and hence, susceptibility to develop obesity.
While many studies examine if maternal environmental
challenges are linked to changes in adiposity or adipocyte
biology in the offspring, the mechanisms underlying these
programming impacts remains largely unknown. Gen-
erally, the molecular analyses performed are targeted and
focus on either adipose inflammation or insulin signaling
pathways, with few studies undertaking wider capturing
analyses, such as RNA sequencing, which would provide a
greater understanding of underlying programming effects.
In addition, mechanisms by which obesity may be pro-
grammed across generations is largely unexplored. Where
there have been studies into transgenerational inheritance,
some studies have found robust changes, suggesting a
change in the offspring heritable epigenome. For example,
in mice, female progeny of obese dams exposed to high-fat
diet displayed obesity and high levels of WAT inflam-
mation in association with hypomethylation at certain
inflammatory genes for three generations [153]. Further-
more, investigations of the Dutch famine cohort found
indications of transgenerational transmission of obesity in
humans [154]. Thus, perhaps the most significant avenue
for the future of this field, is designing studies to further
elucidate the cellular and epigenetic mechanisms under-
lying fetal programming and transgenerational effects.
This is important as the adipose tissue plays a fundamental
role in whole body homeostasis and metabolism and the
potential transgenerational inheritance of obesity maybe
one of the factors contributing to its increase in many
populations worldwide.
Given the current epidemic levels of metabolic diseases
across the globe, the central focus of research in this area
should be on understanding the mechanisms of fetal pro-
gramming in a way to create an optimal in utero environ-
ment to prevent and alleviate disease transmission. This
requires a better understanding of the impact of diet and
hormone exposures on the developing adipose tissue in
humans, as well as a greater knowledge of the influence
these may have on critical events, such as mesenchymal
stem cell fate decisions. It also requires a better under-
standing of the plasticity of adipose tissue across the life
course, as this will help inform on what interventions may
be beneficial in combatting the effects of a poor in utero
environment on the developmental programming of
offspring obesity risk. There have already been interesting
studies in this area, including data showing that maternal
dietary supplementation with methyl donors during gesta-
tion or lactation partially prevented the development of an
obese phenotype in the offspring from high sucrose diet-fed
mothers [155]. This “deprogramming” of offspring phe-
notype via such an approach may prove to be a promising
strategy to overcome the transgenerational transmission of
obesity and help curb the current obesity epidemic and the
high costs to health services worldwide.
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